Mundo, Rechel E.
HRN: 21-18-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/14/2022
CEFUROXIME 1.5GM (VIAL)
05/14/2022
05/14/2022
IV
1.5g
Loading Dose
Thickly MSAF
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamIntra-abdominalReproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes